Nice approves rimegepant for preventing migraines in cases where at least three previous treatments have failed
Thousands of people in England who get migraines could benefit from a drug that has been approved on the NHS.
The National Institute for Health and Care Excellence (Nice), the drugs regulator, said it was recommending rimegepant for preventing migraines in the approximately 145,000 adults where at least three previous preventive treatments had failed.
More Stories
Scientists record seismic tremors from title-clinching Liverpool win over Spurs
Measles outbreak: how contagious is it and what are the symptoms?
Ronan the head-bobbing sea lion proves animals can keep a beat: ‘No human was better’